Atlas Trials

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Clinical trial NCT07265479 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07265479
Sponsor
Organon and Co
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2025-12-29
Primary completion
2027-08-01
Enrollment
187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.